Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
INZY | Inozyme Pharma, Inc. | CEO, Director | $349K | -$52.2K | -13% | Sep 30, 2024 |
CRSP | CRISPR Therapeutics AG | Director | May 30, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|